Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System

This study examines the impact of reporter type on the detection of alopecia-related adverse events from cancer therapies using the FDA Adverse Event Reporting System (FAERS). It found that healthcare professionals (HCPs) tend to report fewer cases of alopecia compared to non-HCPs, suggesting potential underreporting of mild or expected adverse events by HCPs. The study highlights significant differences in reporting patterns, with drugs like docetaxel showing a strong association with alopecia in consumer reports but less so in HCP reports, indicating possible reporting bias. The research underscores the importance of considering reporter characteristics to improve the accuracy and clinical relevance of adverse event data related to alopecia in cancer therapy.